As. Baur et al., Frequent methylation silencing of p15(INK4b) (MTS2) and p16(INK4a) (MTS1) in B-cell and T-cell lymphomas, BLOOD, 94(5), 1999, pp. 1773-1781
The methylation status of p15(INK4b) (MTS2), p16(IK4a) (MTS1) and p14(ARF)
(p16 beta) was analyzed in 56 lymphomas by restriction-enzyme related polym
erase chain reaction (PCR) (REF), methylation-specific PCR (MSP), and bisul
fite genomic sequencing (BGS). Methylation of the p15 and p16 genes was det
ected, respectively, in 64% and 32% of the B-cell lymphomas, in 44% and 22%
of the T-cell lymphomas, and in none of the 5 reactive lymph nodes analyze
d. Both p75 and p16 genes were methylated more often in the high-grade (78%
and 50%, respectively) than in the low-grade B-cell lymphomas (55% and 21%
, respectively). For 5 cases, mapping of the methylated CpGs of the p16 pro
moter region confirmed the results of REP and MSP. In addition, a large var
iation in the methylation patterns of p16 exon 1 was observed, not only fro
m one lymphoma to another, but also within a given tumor. Methylation of p1
5 and p16 was associated with an absence of gene expression, as assessed by
reverse transcription-PCR. The p14 gene was unmethylated and normally expr
essed in all 56 tumors. We found no mutations of p75, p16, or p14 in any of
the 56 lymphomas. Our results suggest a role for p15 and p16 gene methylat
ion during lymphomagenesis and a possible association between p15 and p16 i
nactivation and aggressive transformation in B-cell and T-cell lymphomas. (
C) 1999 by The American Society of Hematology.